Evaluation of rezafungin provisional CLSI clinical breakpoints and epidemiological cutoff values tested against a worldwide collection of contemporaneous invasive fungal isolates (2019 to 2020)
Evaluation of rezafungin provisional CLSI clinical breakpoints and epidemiological cutoff values tested against a worldwide collection of contemporaneous invasive fungal isolates (2019 to 2020) by Carvalhaes CG, Klauer AL, Rhomberg PR, Pfaller MA, Castanheira, M in J. Clin. Microbiol. 2022; 60 (4) doi: 10.1128/jcm.02449-21
